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Introduction
The first case of West Nile virus (WNV) infection in the
United States was reported in New York City in 1999.1,2
Not long thereafter, the number of confirmed cases of
WNV infections escalated from 66 in 2001 to 4,156 in
2002.2,3 In South Dakota, the first 37 cases of WNV infec-
tion emerged in 2002, and by 2003, South Dakota reported
1,039 confirmed human cases. That was exceeded only by
Colorado (2,947) and Nebraska (1,942) in national reported
human cases during 2003.2 These cases in South Dakota
represented 10.5 percent of the confirmed national cases in
2003. As health education and mosquito control efforts
have increased, the incidence of human-confirmed West
Nile virus cases have declined by astonishing measures. In
2009, South Dakota reported only 21 (3.1 percent) of the




Introduction: The purpose of this study was to examine depression and fatigue in individuals with a seropositive
confirmed history of West Nile virus (WNV) infection. 
Methods: The South Dakota State Epidemiologist sent 218 letters inviting residents with a diagnosis of WNV to
participate in the study. Forty-five subjects were tested. An occupational therapist and a physical therapist met with
each participant to assess performance parameters, including depression and fatigue levels. Subjects (n=42) 
completed the Revised Center for Epidemiologic Studies Depression Scale (CES-D) during the assessment. The
Modified Fatigue Impact Scale (MFIS) was sent to participants as a follow-up questionnaire, and 29 were returned.
Subjects were placed within one of three diagnosis groups: West Nile Fever (WNF), West Nile Neuroinvasive
Disease (WNND) and WNV without fever or neuroinvasive disease (clinical/ unspecified). 
Results: Frequency of those reporting low risk of depression was similar between diagnosis groups (each approxi-
mating 75 percent). Depression severity differences were noted, with subjects diagnosed with WNND more likely
to report “severe” risk for depression. Low correlations between depression and overall fatigue, depression and 
cognitive fatigue, and depression and psychosocial fatigue indicators were found. There was little if any correlation
between depression and physical fatigue indicators. Mean CES-D scores for subjects between 13 to 18 months post
infection fell within the mild-moderate risk for depression category. 
Conclusions: Identifying depression risk is useful for patient referral purposes and may help minimize symptoms of
depression correlated with fatigue, especially following hospitalization for WNV infection. 
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Figure 1. 
Annual confirmed cases of West Nile infection in 
South Dakota (including diagnostic classifications).
The majority of WNV cases are mild in nature, and it is 
suspected that a large number (up to 80 percent) of individ-
uals infected with WNV do not know they have been
infected with the virus.5 National statistics estimate about
20 percent of cases result in a condition called West Nile
fever (WNF), while less than 1 percent progress to a more
serious form called West Nile neuroinvasive disease
(WNND).6 In South Dakota, among those with a seroposi-
tive confirmed case of the infection between 2002 and
2009, an average of 74.5 percent experienced WNF, while
an average of 25.3 percent reported WNND and 0.2 percent
were confirmed clinical cases with unspecified symptoms
(C/U) (Figure 2). 
Subjective reports from individuals with a diagnostic history
of WNV include complaints of extreme fatigue.7,8 Watson,
et al.8 determined that 96 percent of those subjects with
WNF reported fatigue lasting a median of 36 days immedi-
ately following diagnosis. Lobe, et al.9 reported patients
with WNV infection experienced symptoms of fatigue up
to an average of four months post-diagnosis and that 
normalization of fatigue levels took longer in patients with
WNND than without. 
Depression is also a symptom commonly reported by 
individuals infected with WNV.7 According to Carson, et
al.,10 of those individuals infected with WNV, 24 percent
experienced moderate-to-severe depression, while only 10
percent of the sample had experienced depression prior to
their infection. This finding may suggest that individuals
infected with WNV are at greater risk for experiencing
clinical depression. According to Murry, et al.,11 31 percent
of study subjects reported new onset of depression a year
after diagnosis, and 75 percent of these cases reported
Center for Epidemiologic Studies Depression Scale (CES-D)
scores which fell within the mild to severe depression risk
categories.12 Sixty-five percent of these new-onset cases of
depression had a diagnosis of WNV encephalitis. Murry, 
et al.11 stated subjective reports of personality changes were
common for individuals after WNV infection. Anxiety and
depression symptoms have also been positively correlated
with a history of WNV infection.7 In addition to anxiety
and depression, individuals have also reported progressive
changes in mood and aggression, as well as increased 
sensitivity and decreased socialization following WNV
infection.7
Based upon a review of the literature, there is evidence to
suggest that those with a history of WNV have an elevated
risk of both depression and fatigue. During the scheduling
and planning stages of this study, evidence from the litera-
ture was supported by subjective reports of commonly
occurring fatigue, mood changes, memory deficits and
depression in this sample. The purpose of this study was to
further examine the prevalence of and relationship
between fatigue and depression in individuals with a 
confirmed history of WNV infection. 
Methods
Subjects
Seropositive confirmed cases of WNV infection between
2002 and 2006 and residing (at time of infection) in one of
nine southeastern South Dakota counties were identified by
the South Dakota Department of Health. The southeastern
region of South Dakota was selected based upon a reason-
able participant proximity to the testing site. To maintain
individual confidentiality, letters were sent by the state epi-
demiologist’s office with investigator contact information
for those interested in participating in this study. 
The South Dakota State Epidemiologist sent 218 letters
inviting subjects with a seropositive confirmed diagnosis of
WNV infection to participate in this study. Of those 
individuals invited, 74 responded to the invitation to 
participate (33.9 percent) and 59 were scheduled for testing
(27.1 percent of population). Respondents were screened to
meet the following inclusion criteria: a seropositive con-
firmed case of WNV infection, English-speaking, age 18 or
older, and no major medical diagnosis since infection (e.g.
stroke, heart attack, Parkinson’s disease, multiple sclerosis,
cancer and the like). 
Ten scheduled individuals did not show up for their testing
appointment, and four subjects cancelled or could not be
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individuals (20.5 percent of the total population). Three
subjects were eliminated from data analysis due to conditions
that may have confounded results. Subject demographics
were as follows: 55 percent male and 45 percent female;
14.3 percent with encephalitis; 7.1 percent with meningitis;
7.1 percent with encephalomeningitis; 52.4 percent with
fever only; and 19.0 percent reporting symptoms without
fever; 28.6 percent were hospitalized for more than 24 hours
(Table 1). Subject age ranged between 35 and 81 years,
with a mean age of 54.4 years (SD=10.7 years). Months
since WNV diagnosis ranged from 13 to 53 months post
infection, with an average time passage of 38.6 months
since diagnosis (SD=15.4 months). 
Instruments 
Center for Epidemiologic Studies Depression scale (CES-D),12
the Brief Fatigue Inventory (FI)13 and the Modified Fatigue
Impact Scale (MFIS)14 were used for the purpose of investi-
gating fatigue and depression. The CES-D is a self-report
assessment consisting of 20 questions related to thoughts
and feelings within the past week. The FI consists of nine
items rated zero (“none”) to 10 (“severe”) addressing current
fatigue levels and surveying the extent to which fatigue
interferes with daily activities, ability to socialize and enjoy-
ment of life. The MFIS is a questionnaire consisting of 21
specific items to assess the effects of fatigue. Results from
the MFIS are reported as a total fatigue score with physical,
cognitive and psychosocial functioning subscales. 
Procedures
Between October 2007 and March 2008, respondents met
with a physical therapist and an occupational therapist for
a 2.5-hour comprehensive assessment session, during which
time functional tests were administered to measure strength,
coordination, balance, endurance, memory, cognition,
activities of daily living and occupational participation,
fatigue and depression levels. All tested subjects completed
the CES-D and the FI during their established assessment
time, and the MFIS was sent to participants as a follow-up
questionnaire to gather more sensitive information about
fatigue measures than the FI. Twenty-nine participants
returned the MFIS questionnaire. 
Participants were given the option to share medical and
rehabilitation records relevant to their course of treatment
for WNV infection. All participants agreed to share these
medical records. Information provided by subjects was 
validated through released medical records. Participants
were assured their information would remain confidential,
and all individuals signed consent forms approved by the
university IRB. All participants were offered a $30 prepaid
credit card as travel compensation. As a follow up to each
participant’s visit, individualized reports were generated by
the occupational therapist and physical therapist and were
sent to each participant and their primary care providers,
upon participant consent. 
Data Analysis 
The study design was a non-experimental, cross-sectional
analysis. Subjects were classified into three diagnostic
groups based upon chart reviews: (1) West Nile Fever
(WNF): those subjects whose medical chart confirmed the
presence of fever (n=22); (2) West Nile Neuroinvasive
Disease (WNND): those subjects whose medical chart con-
firmed the presence of meningitis, encephalitis, or anterior
horn cell involvement resulting in paresis or paralysis
(n=12); and (3) C/U: absence of fever or neurological
expression in the medical records despite seropositive con-
firmation of WNV infection (n=8). 
Spearman’s rho was used to determine any correlation that
existed between CES-D depression scores and MFIS total
fatigue scores as well as between CES-D and MFIS physical,
cognitive and psychosocial subscale scores. A cross tabulation
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Participants were also grouped by time passage following
diagnosis (Table 1), and a one-way ANOVA was adminis-
tered to determine if trends in depression severity were
observed in groups based upon period of time post infection.
LSD post hoc tests were run to determine levels of signifi-
cance, with a level of significance set at 0.05. Data were
analyzed with Statistical Package for Social Sciences
(SPSS) version 17.0.
Results
Frequency of those reporting low risk of depression was 
relatively consistent between diagnostic groups (75.0 percent
of those in WNF and C/U groups and 77.3 percent of those
in the WNND group). Participants with WNND showed
the highest probability for major
depression risk (16.7 percent), followed
by subjects with WNF (9.1 percent;
Figures 3 and 4; Table 2). 
A low correlation15 between depression
and fatigue was determined with r
=.338 (p=.031; Table 3). There was low
correlation between depression indica-
tors and MFIS cognitive fatigue 
indicators (r=.376, p=.015) as well as
between depression and psychosocial
indicators r =.348 (p=.026). There was
little if any15 correlation between
depression and physical fatigue indicators. 
The mean difference in CES-D scores
between those 13 to 18 months post
infection was significant (p=.016)
when compared to those individuals 19 to 36 months post
infection. Mean CES-D score for those in the 13 to 18
month post infection group was 17.1, placing this group’s
mean within the “mild-moderate” risk for depression score
range. All other group means fell within the “low” risk score
range (Table 4). 
Discussion
While it is true that the incidence of WNV infection has
declined as preventive mosquito control measures have
intensified, those with a history of WNV continue to live
with the consequences of infection through activity 
limitations, changes in cognitive functioning, and a 
compromised quality of life.7-12
Figure 3. 
Distribution of subjects within diagnostic classifications into
depression risk categories.
Figure 4/ Table 2.
Percentage distribution of subjects within diagnostic 
classifications, defined by depression risk categories
Table 3. 
Relationship between depression (CES-D scores) and fatigue (MFIS scores) indicators 
as reported by individuals post West Nile virus infection
Table 4. 





Depression and fatigue were among the most prevalent sub-
jectively reported symptoms in this study. Practitioners
should be aware that individuals with a history of WNV
infection, most specifically those with a diagnosis of
WNND, may be at greater risk for severe depression and
may benefit from patient monitoring or referral at early sign
of depression. 
Nearly every participant in this study reported pervasive
fatigue impacting one or all of the following: endurance 
levels, changes in an individual’s ability to engage in work
and activities of daily living, cognitive functioning and 
psychosocial participation. Over and again, tested individ-
uals confided their work capacity was impaired and that
they had quit very meaningful activities because they no
longer had the endurance, stamina or ability to sustain a
sufficient activity level. The low but statistically significant
correlation between cognitive and psychosocial fatigue fac-
tors and depression gives cause for concern that the limita-
tions imposed by fatigue may contribute to depression for
some individuals post WNV infection. 
These authors were surprised to observe that there was 
little to no correlation between the physical fatigue sub-
scale and depression. However, the MFIS physical fatigue
questions probe respondents for high levels of physical
debilitation, which did not appear to be problematic for this
sample population. 
Primary care provider awareness of the risks for depression
associated with WNV infection may guide physician decision-
making when monitoring patients post WNV infection.
This research suggests patients with a history of neuroinva-
sive forms of WNV and those patients who are 13 to 18
months post infection demonstrate the greatest risk for
depression. The primary care provider may desire to 
perform a depression survey tool such as the Patient Health
Questionnaire (PHQ-9)9 when a patient hospitalized 
with WNV infection is discharged. This screen may be
intermittently repeated during the next 18 months of 
follow-up. Such monitoring will give the primary care
provider a discharge point of reference and aid the provider
in identifying patients with depression post infection.
It is fortunate that fewer patients are currently affected by
this viral infection. However, providers should be mindful
of the chronic impact of infection, which may extend years
beyond hospitalization. With this awareness, physicians
should be prepared to refer patients to mental health 
professionals, occupational therapists or other health 
professionals, depending upon the apparent source of
depression. It is in the provider’s best interest to understand
the benefits of monitoring fatigue levels and depression for
these patients in order to address health from a holistic 
perspective. 
The present study had several limitations. First, the study
design did not include an age-matched control group. The
sample size was small, and there was inequitable subject
grouping after diagnostic categorization was completed,
with fewer individuals in the C/U group (n=8) as compared
to the WNF group (N=22). It can be said that this
inequitable distribution is reflective of, though not 
proportionate to, the inequitable distribution of diagnostic
cases of WNV, with the cases of WNF largely outnumber-
ing the cases of WNND and C/U. Subjects were limited to
southeastern South Dakota as a matter of proximity to the
testing site. A choice of moving the testing site, had it been
practically and financially possible, may have drawn a larger
population sample. Furthermore, a low response rate to the
MFIS mailing (69.0 percent), reduced the data set for
fatigue information for an already small sample size. 
Next, because subjects did not complete CES-D and MFIS
results immediately following their infection confirmation,
results were only useful in providing point-in-time data to
identify potential trends between subjects. Longitudinal
individual improvements or increasing debilitation could
not be determined by this type of study design. Finally, sub-
jects may be self-selecting in that those invited participants
with the greatest impairments, least mobility or limited
access to transportation may not have been able to travel to
the assessment clinic for testing; for instance, there were no
subjects with a diagnosis of acute flaccid paralysis, the most
devastating physical expression of WNND. Addressing
these limitations in future studies could provide better 
generalized results. 
In conclusion, this study offers meaningful insight to 
primary care providers working with individuals with a 
history of WNV infection. Providers should be mindful that
patients who have a history of neuroinvasive disease may be
at risk for severe depression, that individuals 13 to 18
months post infection show an elevated risk for depression
and that fatigue and depression are among the most 
frequently reported subjective complaints associated with
long-term functional outcomes following WNV infection. 
Providers should use this information to improve screening,
to appropriately refer, and to monitor patients in the event
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